Antimicrobial resistance in the environment: considerations for current and future risk assessment of veterinary medicinal products - Scientific guideline

The objective of the draft reflection paper is to review available information on the emissions and the environmental fate of veterinary medicinal products as sources of antimicrobial resistance (AMR) and antimicrobial resistant genes to and within the environment, and their risk to human and animal health. The document considers the suitability of the current risk assessment process for AMR and risk mitigation recommendations, and notes knowledge gaps and research needs.

Keywords: antibiotic, environmental fate, human health, animal health, risk assessment, antimicrobial resistance bacteria (ARB), antimicrobial resistance genes (ARGs).

Current version

Reflection paper on antimicrobial resistance in the environment: considerations for current and future risk assessment of veterinary medicinal products - First version

Adopted

Document history

Reflection paper on antimicrobial resistance in the environment: considerations for current and future risk assessment of veterinary medicinal products - First version

Adopted

Overview of comments received on the 'Reflection paper on antimicrobial resistance in the environment: considerations for current and future risk assessment of veterinary medicinal products - First version'

Reference Number: EMA/CVMP/ERA/268948/2020

Draft reflection paper on antimicrobial resistance in the environment: considerations for current and future risk assessment of veterinary medicinal products - First version

Draft: consultation closed Consultation dates: 21/11/2018 to 31/08/2019 Reference Number: EMA/CVMP/ERA/632109/2014